The genetics and neuropathology of amyotrophic lateral sclerosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Acta Neuropathologica

• Publication date

  2012-08-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00401-012-1022-4PMID 22903397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis.

  2012cited by this paper
• UNC13A is a modifier of survival in amyotrophic lateral sclerosis.

  2012cited by this paper
• Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis.

  2012cited by this paper
• VCP mutations in familial and sporadic amyotrophic lateral sclerosis.

  2012cited by this paper
• An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62‐positive, TDP‐43‐negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline

  2012cited by this paper
• Mutation analysis of VCP in familial and sporadic amyotrophic lateral sclerosis.

  2012cited by this paper
• Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.

  2012cited by this paper
• A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.

  2012cited by this paper
• The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.

  2012cited by this paper
• UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis.

  2012cited by this paper
• UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia

  2012cited by this paper
• Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.

  2012cited by this paper
• Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study

  2012cited by this paper
• Ataxin-2 repeat-length variation and neurodegeneration.

  2011cited by this paper
• FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.

  2011cited by this paper
• The risk to relatives of patients with sporadic amyotrophic lateral sclerosis

  2011cited by this paper
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia

  2011influential reference
• A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient.

  2011cited by this paper
• Optineurin in neurodegenerative diseases

  2011cited by this paper
• PolyQ Repeat Expansions in ATXN2 Associated with ALS Are CAA Interrupted Repeats

  2011cited by this paper
• A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling

  2011cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011influential reference
• Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p

  2011cited by this paper
• Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

  2011cited by this paper
• Family history of neurodegenerative and vascular diseases in ALS

  2011cited by this paper
• Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders

  2011cited by this paper
• Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.

  2011cited by this paper
• Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP‐43 proteinopathies but are only rarely additionally immunopositive for phosphorylation‐dependent TDP‐43

  2011cited by this paper
• Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases

  2011cited by this paper
• Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2

  2011cited by this paper
• Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis

  2011cited by this paper
• Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72

  2011cited by this paper
• FUS Immunogold Labeling TEM Analysis of the Neuronal Cytoplasmic Inclusions of Neuronal Intermediate Filament Inclusion Disease: A Frontotemporal Lobar Degeneration with FUS Proteinopathy

  2011cited by this paper
• Proposed criteria for familial amyotrophic lateral sclerosis

  2011cited by this paper
• A yeast functional screen predicts new candidate ALS disease genes

  2011cited by this paper
• p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

  2011cited by this paper
• Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS

  2011cited by this paper
• Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

  2011cited by this paper
• Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.

  2011cited by this paper
• Genetic Variation in KIFAP3 Is Associated with an Upper Motor Neuron-Predominant Phenotype in Amyotrophic Lateral Sclerosis

  2011cited by this paper
• Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease

  2011cited by this paper
• ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import

  2010cited by this paper
• Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease.

  2010cited by this paper
• Familial aggregation in amyotrophic lateral sclerosis

  2010cited by this paper
• Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

  2010cited by this paper
• SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis

  2010cited by this paper
• An estimate of amyotrophic lateral sclerosis heritability using twin data

  2010cited by this paper
• Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

  2010cited by this paper
• Mutations of optineurin in amyotrophic lateral sclerosis

  2010influential reference
• TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.

  2010cited by this paper
• Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis

  2010cited by this paper
• Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase

  2010cited by this paper
• Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS

  2010cited by this paper
• Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients

  2010cited by this paper
• FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosis

  2010cited by this paper
• Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family

  2010cited by this paper
• Exome sequencing reveals VCP mutations as a cause of familial ALS.

  2010cited by this paper
• Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.

  2010cited by this paper
• Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study

  2010cited by this paper
• A new subtype of frontotemporal lobar degeneration with FUS pathology.

  2009cited by this paper
• Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

  2009cited by this paper
• A CASE OF ALS-FTD IN A LARGE FALS PEDIGREE WITH A K17I ANG MUTATION

  2009cited by this paper
• SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis

  2009cited by this paper
• Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis

  2009cited by this paper
• Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.

  2009cited by this paper
• Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

  2009influential reference
• Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

  2009cited by this paper
• Epidemiology of ALS in Italy

  2009cited by this paper
• Rethinking ALS: the FUS about TDP-43.

  2009cited by this paper
• TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

  2008cited by this paper
• TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.

  2008cited by this paper
• TDP‐43 A315T mutation in familial motor neuron disease

  2008cited by this paper
• New VAPB deletion variant and exclusion of VAPB mutations in familial ALS

  2008cited by this paper
• TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

  2008cited by this paper
• Genetics of familial amyotrophic lateral sclerosis

  2008cited by this paper
• TDP‐43 mutation in familial amyotrophic lateral sclerosis

  2008cited by this paper
• Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.

  2008cited by this paper
• Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration

  2008cited by this paper
• Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

  2007cited by this paper
• TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation

  2007cited by this paper
• Disulfide Bond Mediates Aggregation, Toxicity, and Ubiquitylation of Familial Amyotrophic Lateral Sclerosis-linked Mutant SOD1*

  2007cited by this paper
• The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population.

  2007cited by this paper
• Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

  2007cited by this paper
• Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations

  2007cited by this paper
• ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

  2006cited by this paper
• A century-old debate on protein aggregation and neurodegeneration enters the clinic

  2006cited by this paper
• Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment

  2006cited by this paper
• Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis.

  2006cited by this paper
• Amyotrophic lateral sclerosis in an urban setting

  2006cited by this paper
• A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia

  2006cited by this paper
• Molecular biology of amyotrophic lateral sclerosis: insights from genetics

  2006cited by this paper
• ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)

  2006cited by this paper
• Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.

  2006cited by this paper
• Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS

  2005cited by this paper
• A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population

  2005cited by this paper
• Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons

  2005cited by this paper

• Neuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization.

  2026cites this paper
• Aggregates associated with amyotrophic lateral sclerosis sequester the actin-binding protein profilin 2.

  2025cites this paper
• Peripheral transcriptional responses to experimental SARS-CoV-2 inoculation in North American elk cows and calves

  2025cites this paper
• Headache types and characteristics in patients with Amyotrophic Lateral Sclerosis

  2025cites this paper
• MicroRNA Dysregulation in Neurodegeneration: Role, Biomarker Potential, and Therapeutics.

  2025cites this paper
• Miro1: A potential target for treating neurological disorders.

  2025cites this paper
• Dysbiosis and Neurodegeneration in ALS: Unraveling the Gut–Brain Axis

  2025cites this paper
• Genetics of ALS – genes and modifier

  2025cites this paper
• Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases

  2025cites this paper
• C. elegans: a prominent platform for modeling and drug screening in neurological disorders

  2024cites this paper
• Gut microbiota immune cross-talk in amyotrophic lateral sclerosis

  2024cites this paper
• Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS

  2024cites this paper
• Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression.

  2024cites this paper
• Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model

  2024cites this paper
• ALS-associated C21ORF2 variant disrupts DNA damage repair, mitochondrial metabolism, neuronal excitability and NEK1 levels in human motor neurons

  2024cites this paper
• AI in Neurodegenerative Disease Research: IBM Watson Identifying RNA Binding Proteins

  2024cites this paper
• The Current Landscape of Hypotheses Describing the Contribution of CD4+ Heterogeneous Populations to ALS

  2024cites this paper
• Nanozyme enabled protective therapy for neurological diseases

  2024cites this paper
• Single‐cell transcriptomics analysis of cellular heterogeneity and immune mechanisms in neurodegenerative diseases

  2024cites this paper
• The ALS-associated co-chaperone DNAJC7 mediates neuroprotection against proteotoxic stress by modulating HSF1 activity

  2024cites this paper
• The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders

  2023cites this paper
• ERK1/2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respiration in ALS

  2023cites this paper
• The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases

  2023cites this paper
• Theme 04 - In Vivo Experimetal Models

  2023cites this paper
• Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43

  2023cites this paper
• Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review.

  2023cites this paper
• Why should we care about astrocytes in a motor neuron disease?

  2023cites this paper
• Patterns of synaptic loss in human amyotrophic lateral sclerosis spinal cord: a clinicopathological study

  2023cites this paper
• Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits

  2023cites this paper
• Frontotemporal dementia: Addressing the scattered harbingers of genetics and its relationship with glucose metabolism, bipolar disorder, and amyotrophic lateral sclerosis.

  2023cites this paper
• Redox Imbalance in Neurological Disorders in Adults and Children

  2023cites this paper
• Neural circuit and synaptic dysfunctions in ALS-FTD pathology

  2023cites this paper
• Disease-modifying pharmacological treatments for amyotrophic lateral sclerosis/motor neuron disease: an overview of intervention reviews

  2023cites this paper
• Cellular Proteomic Profiling Using Proximity Labeling by TurboID-NES in Microglial and Neuronal Cell Lines

  2023cites this paper
• The Fragile X Protein Family in Amyotrophic Lateral Sclerosis

  2023cites this paper
• Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis

  2023cites this paper
• Modelling dementia in Drosophila uncovers shared and specific targets of TDP-43 proteinopathy across ALS and FTD relevant circuits

  2023influential citation
• The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System

  2022cites this paper
• Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Widespread Mislocalization of FUS Is Associated With Mitochondrial Abnormalities in Skeletal Muscle in Amyotrophic Lateral Sclerosis With FUS Mutations.

  2022cites this paper
• Towards Understanding the Relationship Between ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis

  2022cites this paper
• TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS

  2022cites this paper
• Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies

  2022cites this paper
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression

  2022cites this paper
• Therapeutic Potential of Astrocyte Transplantation

  2022cites this paper
• Hypervoxels: a multidimensional framework for the representation and analysis of neuroimaging data

  2022cites this paper
• Prionoids in amyotrophic lateral sclerosis

  2022cites this paper
• TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP

  2021cites this paper
• Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review

  2021cites this paper
• Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor

  2021cites this paper
• Protein Aggregation in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Cellular bioenergetics in human iPSC–derived glutamatergic neurons in health and disease

  2021cites this paper
• Neurotrophic Therapy for ALS/MND

  2021cites this paper
• Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

  2021cites this paper
• Epigenetic Small Molecules Rescue Nucleocytoplasmic Transport and DNA Damage Phenotypes in C9ORF72 ALS/FTD

  2021cites this paper
• Key Molecular Mechanisms in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)

  2021cites this paper
• Amyotrophe Lateralsklerose und frontotemporale Demenz – auf dem Weg zu gemeinsamen genspezifischen Therapieansätzen

  2021cites this paper
• Modeling C9orf72-Related Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Drosophila

  2021cites this paper
• Cellular proteomic profiling using proximity labelling by TurboID-NES in microglial and neuronal cell lines

  2021cites this paper
• Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient

  2021cites this paper
• Mitochondria Associated Membranes (MAMs): Architecture and physiopathological role.

  2021cites this paper
• The molecular and cellular basis of copper dysregulation and its relationship with human pathologies

  2021cites this paper
• Evidence for a Growing Involvement of Glia in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Small Hexokinase 1 Peptide against Toxic SOD1 G93A Mitochondrial Accumulation in ALS Rescues the ATP-Related Respiration

  2021cites this paper
• How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders

  2021cites this paper
• HnRNP G Reduces Neuron Death in Amyotrophic Lateral Sclerosis by Preventing Abnormal TDP-43 Accumulation

  2021cites this paper
• Ca2+ dysregulation in the pathogenesis of amyotrophic lateral sclerosis.

  2021cites this paper
• Metabolic Dysfunction in Spinal Muscular Atrophy

  2021cites this paper
• A serum microRNA sequence reveals fragile X protein pathology in amyotrophic lateral sclerosis

  2021cites this paper
• Sources and triggers of oxidative damage in neurodegeneration.

  2021cites this paper
• Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy

  2021cites this paper
• The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease

  2020cites this paper
• Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations

  2020cites this paper
• Effect of Non-Enzymatic Glycosylation in the Epigenetics of Cancer.

  2020cites this paper
• Kontroverze - frontotemporální demence a onemocnění motoneuronu - jedno klinické spektrum nebo koincidence?Koincidence

  2020cites this paper
• Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition

  2020cites this paper
• Cortical microstructure in the amyotrophic lateral sclerosis–frontotemporal dementia continuum

  2020cites this paper
• Pro-Oxidant Activity of an ALS-Linked SOD1 Mutant in Zn-Deficient Form

  2020cites this paper
• NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

  2020cites this paper
• The contribution of C. elegans neurogenetics to understanding neurodegenerative diseases

  2020cites this paper
• Reply to: No evidence supports genetic heterogeneity of neuronal intranuclear inclusion disease

  2020cites this paper
• Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment

  2020cites this paper
• Parkin expression reverses mitochondrial dysfunction in fused in sarcoma‐induced amyotrophic lateral sclerosis

  2020cites this paper
• Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research

  2020cites this paper
• A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis

  2020cites this paper
• MicroRNA‐183‐5p is stress‐inducible and protects neurons against cell death in amyotrophic lateral sclerosis

  2020cites this paper
• What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?

  2020cites this paper
• The Peripheral Immune System and Amyotrophic Lateral Sclerosis

  2020cites this paper
• Downregulation of miR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis

  2020cites this paper
• Low Level of Expression of C-Terminally Truncated Human FUS Causes Extensive Changes in the Spinal Cord Transcriptome of Asymptomatic Transgenic Mice

  2020cites this paper
• The role of mitochondria-associated membranes in cellular homeostasis and diseases.

  2020cites this paper
• Caenorhabditis elegans as a model organism for protein homeostasis diseases

  2020cites this paper
• Human-lineage-specific genomic elements: relevance to neurodegenerative disease and APOE transcript usage

  2020cites this paper
• Locomotor deficits in ALS mice are paralleled by loss of V1-interneuron-connections onto fast motor neurons

  2020cites this paper
• Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1G93A Mice

  2020cites this paper
• Structural Variants May Be a Source of Missing Heritability in sALS

  2020cites this paper
• Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD

  2020cites this paper
• Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans

  2020cites this paper
• Profiling the unique protective properties of intracranial arterial endothelial cells

  2019cites this paper